Randomised open label cross-over study into the efficacy of RApamycin in children with Tuberous sclerosis complex with intractable Epilepsy (RATE-trial).
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2015
At a glance
- Drugs Sirolimus (Primary)
- Indications Epilepsy
- Focus Therapeutic Use
- Acronyms RATE
- 19 Dec 2011 Planned End Date changed from 30 Nov 2013 to 31 Aug 2014 as reported by Netherlands Trial Register record.
- 19 Dec 2011 Additional trial centre and investigator identified as reported by Netherlands Trial Register record.
- 18 Dec 2011 New source identified and integrated (Netherlands Trial Register).